Drug intelligence / Profile preview

Clinpro Tooth Crème (3M)

Development stage: Unknown
Lead developer: 3M
Modality: Small Molecules
Administration: Topical

Overview

Clinpro Tooth Crème is an anti-cavity dentifrice developed by 3M ESPE containing 0.21% w/w sodium fluoride (950 ppm) and a proprietary functionalized tricalcium phosphate (f-TCP) technology. It is primarily indicated for the prevention of dental caries and the remineralization of enamel, particularly in the treatment of white spot lesions following orthodontic treatment. The f-TCP component is designed to remain stable in the presence of fluoride until it reaches the saliva-bathed tooth surface, where it releases calcium and phosphate ions to enhance the remineralization process and improve microhardness. It is also used to manage dentine hypersensitivity by occluding dentinal tubules.

Brand names: Clinpro Tooth Crème
Other names: Clinpro CrèmeClinpro

Beyond the preview

Go deeper on Clinpro Tooth Crème (3M).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clinpro Tooth Crème (3M).

Explore the full profile